What clinical trials are available for recurrent Colorectal Cancer
Clinical Trials for Recurrent Colorectal Cancer
I appreciate your question about clinical trial options. While I have access to comprehensive NCCN Guidelines for colorectal cancer treatment, the specific guidelines provided don't include a detailed registry of currently active clinical trials. However, I can explain the treatment landscape and how to find trials that may be relevant to your situation.
Treatment Approaches for Recurrent CRC
According to NCCN Guidelines Version 5.2025 for Colon Cancer, the Panel emphasizes that "treating patients in a clinical trial has priority over standard or accepted therapy." This means clinical trials should be considered as a first-line option alongside standard treatments.
For recurrent colorectal cancer, treatment typically depends on:
Key Factors Your Team Will Consider:
- Previous chemotherapy history - what you've already received
- Biomarker status - specifically:
- MSI/MMR status (mismatch repair deficiency or microsatellite instability)
- KRAS/NRAS mutations
- BRAF mutations
- HER2 amplifications
- Location and extent of recurrence (local vs. distant metastases)
- Time since initial treatment
General Treatment Categories (Where Trials Often Focus)
According to NCCN Guidelines, systemic therapy options for recurrent/progressive disease include:
Chemotherapy-based approaches:
- FOLFOX, FOLFIRI, FOLFOXIRI combinations
- Fluoropyrimidine monotherapy
Targeted therapies:
- Bevacizumab (anti-angiogenic agent)
- Cetuximab or panitumumab (for KRAS wild-type tumors)
- Regorafenib (for refractory disease)
- TAS-102 (trifluridine-tipiracil)
Immunotherapy (for specific biomarker profiles):
- Nivolumab and ipilimumab combinations (for dMMR/MSI-H tumors)
- Dostarlimab (for mismatch repair deficient tumors)
How to Find Clinical Trials
Official Resources:
-
ClinicalTrials.gov (https://clinicaltrials.gov)
- Search: "colorectal cancer" + "recurrent" or "metastatic"
- Filter by location, trial phase, and recruitment status
-
Your Cancer Center's Research Department
- Ask your oncologist directly about trials they're affiliated with
- Many academic centers have dedicated trial coordinators
-
Cancer-Specific Resources:
- American Cancer Society - has trial matching services
- National Cancer Institute (NCI) - Cancer.gov has trial finder tools
- NCCN Member Institutions - often have robust trial portfolios
-
Disease Advocacy Organizations:
- Colorectal Cancer Alliance
- Fight Colorectal Cancer
- These often maintain trial databases specific to CRC
Questions to Ask Your Oncologist About Trials
-
"Are there any clinical trials available for my specific biomarker profile (MSI/MMR status, KRAS/BRAF status)?"
-
"What trials is our cancer center currently enrolling for recurrent colorectal cancer?"
-
"Based on my previous treatments, which trial approaches might be most appropriate?"
-
"What are the potential benefits and risks of the trial compared to standard treatment options?"
-
"If I enroll in a trial, can I switch to standard treatment if the trial isn't working?"
-
"How will my progress be monitored, and how often will I need to visit the center?"
Important Context
The NCCN Panel stresses that "recommendations for patients with disseminated metastatic disease represent a continuum of care in which lines of treatment are blurred rather than discrete." This means your treatment plan may evolve based on how your cancer responds, and trials may be available at different points in your treatment journey.
Next Steps
I strongly recommend:
- Ask your oncologist to review your tumor's biomarker results with you
- Request a list of trials your center is currently enrolling
- Visit ClinicalTrials.gov and search with your specific diagnosis and biomarker status
- Contact your local cancer center's research coordinator
Your oncologist will determine which trials are most appropriate for YOUR specific situation based on your complete medical history, previous treatments, and tumor characteristics.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions about clinical trial participation.
Your next question, already answered
Tap to keep going. 2 free answers, then a free account.
Ask Navis about your case
That answer is general. Ask about your specific situation. Answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Sources & medical oversight
- Grounded in NCCN Guidelines for Patients: Colon Cancer — the same guidelines oncologists use.
- Built by OpenCancer’s team of physician-scientists and cancer survivors.
- Last updated May 17, 2026. Informational only — not a substitute for your oncology team.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Source Guidelines
NCCN Guidelines for Patients: Colon Cancer (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with clinical trials for Colorectal Cancer patients
Have your records handy? Add them to a private case for a deeper, personalized read →
More questions about Colorectal Cancer
- What questions should I ask about a Colorectal Cancer clinical trial
- What are the latest clinical trials for Colorectal Cancer in 2026
- Is recurrent Colorectal Cancer harder to treat than the original
- What should I consider when choosing between clinical trial and standard treatment for Colorectal Cancer
- What is a cancer vaccine and is one available for Colorectal Cancer
- What targeted therapies are available for Colorectal Cancer
- What palliative care options are available for Colorectal Cancer
- What is the difference between phase 1, 2, and 3 trials for Colorectal Cancer